The American Society of Echocardiography (ASE) and Ke Labs jointly announced in May an agreement to co-develop and co-market a new cardiac ultrasound software application. The application is designed to ensure quality and consistency of cardiac ultrasound image review — both quantitatively and qualitatively — and inform and educate users on interesting cases, new techniques and other changes. This medical imaging quality management software tool is generally referred to as the “Echocardiography Test and Teach Application,” and it has been designed through the expert guidance of Harvey Feigenbaum, M.D., FASE with the Krannert Institute of Cardiology at Indiana University Health and founder of the ASE.

IMRIS Inc. received a letter May 26 from the NASDAQ Stock Market stating that it would be delisted and trading suspended on June 4. IMRIS said this was in accordance with Listing Rules 5101, 5110(b), and IM-5101-1. A Form 25-NSE will be filed with the Securities and Exchange Commission (the SEC), which will remove the company's securities from listing and registration on The Nasdaq Stock Market.

Richardson Electronics, Ltd. today announced the signing of a definitive agreement to acquire the assets of International Medical Equipment and Service, Inc. (IMES). IMES is the first acquisition completed by Richardson Healthcare, the division of Richardson Electronics focused on high-value components and replacement parts for the diagnostic imaging market.

vRad (Virtual Radiologic), a leading telemedicine company and radiology practice, and MetaMind, Inc., a provider of state-of-the-art Artificial Intelligence (AI) solutions powered by “deep learning,” announced a partnership to improve the speed, accuracy and quality of radiology diagnostics for a series of potentially life-threatening conditions, the first of which will be intracranial hemorrhaging (IH). IH (blood leaking inside the brain) requires immediate medical treatment, otherwise it quickly leads to increased pressure in the brain, and potentially damaged brain tissue or death.

iCAD Inc. announced the first Xoft Axxent Electronic Brachytherapy (eBx) System in Spain is now available at the Hospital Miguel Servet for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers. iCAD highlighted the Xoft System at the third European Society for Radiotherapy and Oncology (ESTRO) Forum in Barcelona, April 24-28.